Regulation
Wandercraft’s self-balancing exoskeleton wins FDA clearance
Wandercraft received FDA clearance for its self-balancing exoskeleton designed to support upright movement in paralyzed patients. The company plans to launch the device in the US market in September 2026.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network